Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1969]

Efficacy and safety of KRd or KCd induction in multiple myeloma

Dr Francesca Gay - University of Torino, Torino, Italy

Efficacy and safety of KRd or KCd induction in multiple myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )

Maintenance therapy with the oral PI ixazomib significantly prolongs PFS...

Dr Francesca Gay - University of Torino, Torino, Italy

Maintenance therapy with the oral PI ixazomib significantly prolongs PFS following ASCT in multiple myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )

Results from the EMN-011 trial, combination therapy for multiple myeloma

Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands

Results from the EMN-011 trial, combination therapy for multiple myeloma ( Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands )

Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative...

Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France

Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative disorder in the central nervous system ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )

Clinical impact of an accurate genetic characterisation of older AML patients

Prof Alessandro Rambaldi - University of Milan, Milan, Italy

Clinical impact of an accurate genetic characterisation of older AML patients ( Prof Alessandro Rambaldi - University of Milan, Milan, Italy )

Two clinical trials using combination therapy in adult patients with multiple...

Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA

Two clinical trials using combination therapy in adult patients with multiple myeloma ( Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA )

The combined analysis of carfilzomib trials for multiple myeloma

Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain

The combined analysis of carfilzomib trials for multiple myeloma ( Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain )

Gilteritinib combined with induction and consolidation chemotherapy in newly...

Dr Keith Pratz - Johns Hopkins University, Baltimore, USA

Gilteritinib combined with induction and consolidation chemotherapy in newly diagnosed AML patients ( Dr Keith Pratz - Johns Hopkins University, Baltimore, USA )

Axicabtagene Ciloleucel in patients with refractory large B Cell lymphoma

Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA

$Axicabtagene Ciloleucel in patients with refractory large B Cell lymphoma ( Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA )$

Matched targeted therapy for paediatric patients with relapsed, refractory or...

Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA

$Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias ( Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA )$

Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for...

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for children with acute leukaemia ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )

Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor...

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

$Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor relapsed/refractory ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )$

More from ecancer